122 related articles for article (PubMed ID: 9021684)
1. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
Neri A; Fracchiolla NS; Migliazza A; Trecca D; Lombardi L
Leuk Lymphoma; 1996 Sep; 23(1-2):43-8. PubMed ID: 9021684
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.
Migliazza A; Lombardi L; Rocchi M; Trecca D; Chang CC; Antonacci R; Fracchiolla NS; Ciana P; Maiolo AT; Neri A
Blood; 1994 Dec; 84(11):3850-60. PubMed ID: 7949142
[TBL] [Abstract][Full Text] [Related]
3. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
Zhang J; Chang CC; Lombardi L; Dalla-Favera R
Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
[TBL] [Abstract][Full Text] [Related]
4. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
Fracchiolla NS; Lombardi L; Salina M; Migliazza A; Baldini L; Berti E; Cro L; Polli E; Maiolo AT; Neri A
Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
[TBL] [Abstract][Full Text] [Related]
5. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Mol Cell Biol; 1995 Sep; 15(9):5180-7. PubMed ID: 7651435
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI; Beg AA; Baldwin AS
Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
8. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
Neri A; Chang CC; Lombardi L; Salina M; Corradini P; Maiolo AT; Chaganti RS; Dalla-Favera R
Cell; 1991 Dec; 67(6):1075-87. PubMed ID: 1760839
[TBL] [Abstract][Full Text] [Related]
9. Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).
Duckett CS; Perkins ND; Kowalik TF; Schmid RM; Huang ES; Baldwin AS; Nabel GJ
Mol Cell Biol; 1993 Mar; 13(3):1315-22. PubMed ID: 8441377
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
[TBL] [Abstract][Full Text] [Related]
11. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
Beg AA; Baldwin AS
Oncogene; 1994 May; 9(5):1487-92. PubMed ID: 8152812
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
[TBL] [Abstract][Full Text] [Related]
13. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
Mercurio F; Didonato J; Rosette C; Karin M
DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
[TBL] [Abstract][Full Text] [Related]
15. Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.
Liptay S; Schmid RM; Perkins ND; Meltzer P; Altherr MR; McPherson JD; Wasmuth JJ; Nabel GJ
Genomics; 1992 Jun; 13(2):287-92. PubMed ID: 1612589
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
Naumann M; Nieters A; Hatada EN; Scheidereit C
Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
[TBL] [Abstract][Full Text] [Related]
17. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
Mercurio F; DiDonato JA; Rosette C; Karin M
Genes Dev; 1993 Apr; 7(4):705-18. PubMed ID: 8458581
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively.
Le Beau MM; Ito C; Cogswell P; Espinosa R; Fernald AA; Baldwin AS
Genomics; 1992 Oct; 14(2):529-31. PubMed ID: 1427874
[TBL] [Abstract][Full Text] [Related]
19. The generation of nfkb2 p52: mechanism and efficiency.
Heusch M; Lin L; Geleziunas R; Greene WC
Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
[TBL] [Abstract][Full Text] [Related]
20. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
